• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

566 例泰国系统性硬化症患者的临床特征和结局:一项队列研究。

Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study.

机构信息

Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

CKDnet, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Int J Rheum Dis. 2020 Jul;23(7):945-957. doi: 10.1111/1756-185X.13859. Epub 2020 May 18.

DOI:10.1111/1756-185X.13859
PMID:32420701
Abstract

BACKGROUND

Most Thai patients with systemic sclerosis (SSc) have diffuse cutaneous SSc (dcSSc) unlike most Caucasians and some Asians. A longitudinal cohort study among Thai dcSSc is needed.

OBJECTIVES

We aimed to determine the overall clinical characteristics, define the clinical difference between limited cutaneous SSc (lcSSc) and dcSSc, and ascertain the mortality rate and the factors associated with mortality.

METHOD

We conducted a cohort study including 566 Thai adult SSc patients between January 2013 and June 2019. Clinical difference between lcSSc and dcSSc was investigated using generalized estimating equations (GEE).

RESULTS

Females presented more than males (356 vs 210 cases). The majority of cases were dcSSc (411; 72.6%). The median duration of disease at the time of pulmonary fibrosis (PF) detection was 2.5 years, pulmonary arterial hypertension 8.1 years, and renal crisis 4.1 years. By GEE analysis, dcSSc was significantly associated with salt-and-pepper skin, hand deformity, and every 1-point increase in modified Rodnan skin score (mRSS). A greater mortality risk was associated with age at onset >60 years (hazards ratio [HR] 5.5), a World Health Organization functional class (FC) III (HR 5.1), FC IV (HR 34.8), edematous skin (HR 11.4), early onset of PF (HR 1.7), each 5-point increase in the mRSS (HR 4.5), and ≥2 internal organ involvements (HR 10.1).

CONCLUSION

dcSSc is a common SSc subset among Thais. PF was an early complication in SSc and earlier PF detection was associated with a poorer prognosis. Elderly onset, high FC, severe skin tightness, and multiple organ involvements were associated with a greater mortality risk.

摘要

背景

与大多数白人和一些亚洲人不同,大多数泰国系统性硬化症(SSc)患者为弥漫性皮肤型 SSc(dcSSc)。需要对泰国 dcSSc 患者进行纵向队列研究。

目的

我们旨在确定总体临床特征,定义局限性皮肤型 SSc(lcSSc)和 dcSSc 之间的临床差异,并确定死亡率和与死亡率相关的因素。

方法

我们进行了一项队列研究,纳入了 2013 年 1 月至 2019 年 6 月期间的 566 例泰国成年 SSc 患者。使用广义估计方程(GEE)来研究 lcSSc 和 dcSSc 之间的临床差异。

结果

女性多于男性(356 例比 210 例)。大多数患者为 dcSSc(411 例,占 72.6%)。在检测到肺纤维化(PF)时疾病的中位病程为 2.5 年,肺动脉高压为 8.1 年,肾危象为 4.1 年。通过 GEE 分析,dcSSc 与椒盐皮肤、手部畸形和改良 Rodnan 皮肤评分(mRSS)每增加 1 分显著相关。发病年龄>60 岁(危险比 [HR] 5.5)、世界卫生组织功能分级(FC)Ⅲ级(HR 5.1)、FC Ⅳ级(HR 34.8)、水肿性皮肤(HR 11.4)、PF 早期发病(HR 1.7)、mRSS 每增加 5 分(HR 4.5)和≥2 个内脏器官受累(HR 10.1)与更高的死亡风险相关。

结论

dcSSc 是泰国 SSc 的常见亚型。PF 是 SSc 的早期并发症,更早的 PF 检测与更差的预后相关。发病年龄较大、FC 较高、严重的皮肤紧绷和多个器官受累与更高的死亡风险相关。

相似文献

1
Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study.566 例泰国系统性硬化症患者的临床特征和结局:一项队列研究。
Int J Rheum Dis. 2020 Jul;23(7):945-957. doi: 10.1111/1756-185X.13859. Epub 2020 May 18.
2
Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.泰国抗拓扑异构酶I阳性与阴性系统性硬化症患者的临床差异
Int J Rheum Dis. 2016 Mar;19(3):312-20. doi: 10.1111/1756-185X.12492. Epub 2014 Oct 8.
3
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.系统性硬化症的间质性肺疾病:来自西班牙硬皮病研究组的数据。
Rheumatol Int. 2018 Mar;38(3):363-374. doi: 10.1007/s00296-017-3916-x. Epub 2018 Jan 10.
4
Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.泰国系统性硬化症患者临床和自身抗体谱的相关性
Int J Rheum Dis. 2017 Oct;20(10):1572-1581. doi: 10.1111/1756-185X.13060. Epub 2017 Mar 10.
5
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.利用自身抗体和皮肤亚群制定基于结局的系统性硬化病疾病分类。
Arthritis Rheumatol. 2020 Mar;72(3):465-476. doi: 10.1002/art.41153. Epub 2020 Jan 28.
6
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.无皮肤硬化系统性硬皮病患者的皮肤表现、临床特征和预后:来自国际 EUSTAR 数据库的数据。
JAMA Dermatol. 2023 Aug 1;159(8):837-847. doi: 10.1001/jamadermatol.2023.1729.
7
Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.抗拓扑异构酶I抗体阳性的系统性硬化症患者的临床亚组、皮肤厚度进展率及血清抗体水平
Arthritis Rheum. 2007 Aug;56(8):2740-6. doi: 10.1002/art.22747.
8
Prevalence and predictors of hand involvement in Thai patients with systemic sclerosis.泰国系统性硬化症患者手部受累的患病率及预测因素
Int J Rheum Dis. 2018 Jan;21(1):240-248. doi: 10.1111/1756-185X.12919. Epub 2016 Jul 26.
9
Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study.泰国早期系统性硬化症患者的死亡原因、生存情况和死亡风险因素:一项发病队列研究。
Rheumatol Int. 2017 Dec;37(12):2087-2094. doi: 10.1007/s00296-017-3846-7. Epub 2017 Oct 12.
10
Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.西班牙系统性硬皮病网络注册研究:根据皮肤亚型和免疫状态的临床表现。
Semin Arthritis Rheum. 2012 Jun;41(6):789-800. doi: 10.1016/j.semarthrit.2011.10.004. Epub 2011 Dec 12.

引用本文的文献

1
Effects of a Self-Management Telehealth Program on Improving Strength and Hand Function in Systemic Sclerosis Patients: A Randomized Controlled Trial.一项自我管理远程医疗计划对改善系统性硬化症患者力量和手部功能的影响:一项随机对照试验。
Life (Basel). 2025 Jul 10;15(7):1087. doi: 10.3390/life15071087.
2
Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset.重新定义系统性硬化症的分类:与局限性皮肤型系统性硬化症亚组相比,抗拓扑异构酶抗体是间质性肺病和皮肤进展的更优预测指标。
Life (Basel). 2025 Jul 4;15(7):1067. doi: 10.3390/life15071067.
3
Validation and cross-cultural adaptation of the Thai version of the Systemic Sclerosis Health Assessment Questionnaire.
系统性硬化症健康评估问卷泰语版的验证与跨文化调适
Clin Rheumatol. 2025 Jul 1. doi: 10.1007/s10067-025-07553-2.
4
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.间质性肺异常的评估与管理方法:美国胸科学会官方临床声明
Am J Respir Crit Care Med. 2025 Jul;211(7):1132-1155. doi: 10.1164/rccm.202505-1054ST.
5
Correlation Between the Peak of Skin Thickness Progression Rate and Onset of Cardiopulmonary Involvement in Thai Systemic Sclerosis Patients.泰国系统性硬化症患者皮肤厚度进展率峰值与心肺受累发病之间的相关性
J Clin Med. 2025 Mar 27;14(7):2281. doi: 10.3390/jcm14072281.
6
Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis.亚太地区系统性硬化症的流行病学:一项系统评价和荟萃分析。
Ann Med. 2025 Dec;57(1):2479238. doi: 10.1080/07853890.2025.2479238. Epub 2025 Mar 21.
7
Scleroderma renal crisis, an increasingly rare but persistently challenging condition: a retrospective cohort study.硬皮病肾危象,一种日益罕见但始终具有挑战性的病症:一项回顾性队列研究。
Rheumatol Adv Pract. 2024 Oct 28;8(4):rkae131. doi: 10.1093/rap/rkae131. eCollection 2024.
8
A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018-2024.系统性硬化症及其器官表现的流行病学范围综述:2018 - 2024年
Curr Opin Rheumatol. 2025 Mar 1;37(2):103-112. doi: 10.1097/BOR.0000000000001063. Epub 2024 Oct 23.
9
Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study.系统性硬化症患者左心室收缩功能障碍的临床病程及预测因素:一项队列研究。
Rheumatol Immunol Res. 2024 Jul 15;5(2):107-116. doi: 10.1515/rir-2024-0014. eCollection 2024 Jun.
10
Pulmonary function in Thai patients with systemic sclerosis; a single center 6-year retrospective study.泰国系统性硬化症患者的肺功能:单中心 6 年回顾性研究。
F1000Res. 2024 May 31;13:296. doi: 10.12688/f1000research.146498.2. eCollection 2024.